Advanced technologies for the development of infectious disease vaccines
Vaccines play a critical role in the prevention of life-threatening infectious disease. However,
the development of effective vaccines against many immune-evading pathogens such as …
the development of effective vaccines against many immune-evading pathogens such as …
Advanced materials for SARS‐CoV‐2 vaccines
MT Mabrouk, WC Huang… - Advanced …, 2022 - Wiley Online Library
The ongoing coronavirus disease 2019 (COVID‐19) pandemic, caused by severe acute
respiratory coronavirus 2 (SARS‐CoV‐2), has killed untold millions worldwide and has …
respiratory coronavirus 2 (SARS‐CoV‐2), has killed untold millions worldwide and has …
[HTML][HTML] Vaccination with a structure-based stabilized version of malarial antigen Pfs48/45 elicits ultra-potent transmission-blocking antibody responses
B McLeod, MT Mabrouk, K Miura, R Ravichandran… - Immunity, 2022 - cell.com
Malaria transmission-blocking vaccines (TBVs) aim to elicit human antibodies that inhibit
sporogonic development of Plasmodium falciparum in mosquitoes, thereby preventing …
sporogonic development of Plasmodium falciparum in mosquitoes, thereby preventing …
SARS-CoV-2 spike protein accumulation in the skull-meninges-brain axis: potential implications for long-term neurological complications in post-COVID-19
ABSTRACT Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory
syndrome coronavirus type 2 (SARS-CoV-2), has been associated mainly with a range of …
syndrome coronavirus type 2 (SARS-CoV-2), has been associated mainly with a range of …
CoPoP liposomes displaying stabilized clade C HIV-1 Env elicit tier 2 multiclade neutralization in rabbits
A Koornneef, K Vanshylla, G Hardenberg… - Nature …, 2024 - nature.com
One of the strategies towards an effective HIV-1 vaccine is to elicit broadly neutralizing
antibody responses that target the high HIV-1 Env diversity. Here, we present an HIV-1 …
antibody responses that target the high HIV-1 Env diversity. Here, we present an HIV-1 …
Organic coordination nanoparticles for phototheranostics
Nanomedicines can integrate multiple functionalities to improve the efficacy of disease
treatment with reduced off-target toxicity. However, challenges such as tedious synthesis …
treatment with reduced off-target toxicity. However, challenges such as tedious synthesis …
Advances of Nanotechnology Toward Vaccine Development Against Animal Infectious Diseases
X Wang, X Gao, L Wang, J Lin… - Advanced Functional …, 2023 - Wiley Online Library
Vaccines are the most effective means of controlling infectious diseases. Increasingly
epidemics have driven the development of vaccines for human use. However, insufficient …
epidemics have driven the development of vaccines for human use. However, insufficient …
A comparison between SARS-CoV-1 and SARS-CoV2: an update on current COVID-19 vaccines
G Abdolmaleki, MA Taheri, S Paridehpour… - DARU Journal of …, 2022 - Springer
Since the outbreak of the novel coronavirus disease 2019 (COVID-19) in Wuhan, China,
many health care systems have been heavily engaged in treating and preventing the …
many health care systems have been heavily engaged in treating and preventing the …
[HTML][HTML] Leveraging immunoliposomes as nanocarriers against SARS-CoV-2 and its emerging variants
The global COVID-19 pandemic arising from SARS-CoV-2 has impacted many lives, gaining
interest worldwide ever since it was first identified in December 2019. Till 2023, 752 million …
interest worldwide ever since it was first identified in December 2019. Till 2023, 752 million …
Intranasal immunization with liposome-displayed receptor-binding domain induces mucosal immunity and protection against SARS-CoV-2
The global pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2), has led to efforts in develo** effective vaccine approaches. Currently, approved …
CoV-2), has led to efforts in develo** effective vaccine approaches. Currently, approved …